| 1 |
34691416 | Comprehensive management of refractory autoimmune hemolytic anemia in pediatric beta-thalassemia major patient: A case report. | 2021 Oct |
1 |
| 2 |
32676025 | Probable Drug Interaction Between Etanercept and Cyclosporine Resulting in Clinically Unexpected Low Trough Concentrations: First Case Report. | 2020 |
1 |
| 3 |
30880061 | Modulation of innate immunity by cyclosporine A. | 2019 May |
1 |
| 4 |
31332983 | Factors Predicting the Response to Cyclosporin Treatment in Patients With Chronic Spontaneous Urticaria: A Systematic Review. | 2019 Sep |
1 |
| 5 |
30048737 | Development and utilization of a unique in vitro antigen presentation co-culture model for detection of immunomodulating substances. | 2018 Dec |
2 |
| 6 |
27651429 | Frontline Science: Placenta-derived decidual stromal cells alter IL-2R expression and signaling in alloantigen-activated T cells. | 2017 Mar |
1 |
| 7 |
27367933 | The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®. | 2016 Oct |
1 |
| 8 |
25817300 | Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients. | 2015 Jun |
1 |
| 9 |
25883698 | Fungal infections in renal transplant patients. | 2015 Jun |
1 |
| 10 |
26250536 | Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2. | 2015 Aug |
1 |
| 11 |
26527872 | Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity. | 2015 |
1 |
| 12 |
23943055 | Delphinidin activates NFAT and induces IL-2 production through SOCE in T cells. | 2014 Apr |
1 |
| 13 |
24929014 | Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A. | 2014 Sep 10 |
1 |
| 14 |
24969967 | Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2. | 2014 Oct |
1 |
| 15 |
25143337 | Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis. | 2014 Oct |
2 |
| 16 |
23840803 | Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism. | 2013 |
2 |
| 17 |
24028719 | [Inhibitory effects of tacrolimus on effector T cells from patients with severe aplastic anemia]. | 2013 May 28 |
1 |
| 18 |
24218893 | [Traffic-related PM2.5 regulates IL-2 releasing in Jurkat T cells by calcium signaling pathway]. | 2013 Sep |
1 |
| 19 |
22687422 | Tributylhexadecylphosphonium bromide, a novel nuclear factor of activated T cells signaling inhibitor, blocks interleukin-2 induction associated with inhibition of p70 ribosomal protein S6 kinase phosphorylation. | 2012 |
1 |
| 20 |
22743548 | In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. | 2012 Jul 27 |
2 |
| 21 |
22743722 | Association of transforming growth factor β1 (TGF- β1) with gingival hyperplasia in heart transplant patients undergoing cyclosporine-A treatment. | 2012 Apr-Jun |
1 |
| 22 |
22929409 | Increased cyclosporin a sensitivity in vivo in pediatric renal transplant recipients compared with adults. | 2012 Oct |
2 |
| 23 |
23146536 | Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil. | 2012 Nov |
2 |
| 24 |
24175257 | Treatment of young patients with lupus nephritis using calcineurin inhibitors. | 2012 Dec 6 |
2 |
| 25 |
21078360 | Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling. | 2011 Feb |
2 |
| 26 |
21304046 | New minimal immunosuppression strategies for composite tissue allograft transplantation: the cleveland clinic experience. | 2011 |
1 |
| 27 |
21401729 | Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response. | 2011 Jun |
1 |
| 28 |
20578209 | Sotrastaurin and cyclosporine drug interaction study in healthy subjects. | 2010 Jul |
1 |
| 29 |
20583270 | Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells. | 2010 Jul |
2 |
| 30 |
20718971 | Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox. | 2010 Aug 18 |
1 |
| 31 |
21129276 | [Preliminary study on role of endothelial cells and tissue factor in graft-versus-host disease]. | 2010 Oct |
1 |
| 32 |
19336891 | Evaluation of interleukin-2 mRNA in whole blood as a parameter for monitoring cyclosporine pharmacodynamics. | 2009 Apr |
4 |
| 33 |
19857752 | Inhibitory effects of cyclosporine on human regulatory T cells in vitro. | 2009 Oct |
2 |
| 34 |
19930311 | AEB071--a promising immunosuppressive agent. | 2009 Dec |
1 |
| 35 |
19930321 | In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus. | 2009 Dec |
2 |
| 36 |
18410372 | Monitoring treatment with cyclosporine microemulsion in myasthenia gravis. | 2008 Jun |
1 |
| 37 |
18570909 | [Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist]. | 2008 Mar |
1 |
| 38 |
18981654 | Cyclosporine A inhibits transcription of cytokine genes and decreases the frequencies of IL-2 producing cells in feline mononuclear cells. | 2008 Oct |
1 |
| 39 |
19707465 | Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels. | 2008 Dec |
1 |
| 40 |
17000002 | A humanized monoclonal antibody against interleukin-2 that can inactivate the cytokine/receptor complex. | 2007 Mar |
2 |
| 41 |
17227295 | Pharmacodynamics of T-cell function for monitoring immunosuppression. | 2007 Feb |
1 |
| 42 |
17227616 | Evaluation of metered dose inhaler (MDI) formulations of ciclosporin. | 2007 Jan |
4 |
| 43 |
17299267 | Novel immunosuppressant agents targeting activated lymphocytes by biocompatible MPC polymer conjugated with interleukin-2. | 2007 |
2 |
| 44 |
17565322 | Interleukin-21: an interleukin-2 dependent player in rejection processes. | 2007 Jun 15 |
3 |
| 45 |
17580145 | Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies. | 2007 Jun |
1 |
| 46 |
17617853 | Effects of cyclosporine on transplant tolerance: the role of IL-2. | 2007 Aug |
4 |
| 47 |
17761346 | Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cells. | 2007 Nov |
1 |
| 48 |
17880416 | Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells. | 2007 Oct |
2 |
| 49 |
18089333 | Cyclosporine monitoring in peripheral blood mononuclear cells: feasibility and interest. A prospective study on 20 renal transplant recipients. | 2007 Dec |
2 |
| 50 |
16431291 | Apoptosis of allospecifically activated human helper T cells is blocked by calcineurin inhibition. | 2006 Jan |
1 |